Pediatrics & Neonatology,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 1, 2024
Alport
syndrome
(AS)
is
the
second
common
monogenic
cause
of
end-stage
kidney
disease
(ESKD)
worldwide
and
caused
by
defective
type
4
collagen
due
to
pathogenic
variants
COL4A3,
COL4A4,
or
COL4A5.
Type
also
exists
in
eyes
ears,
thus
ocular
defects
hearing
loss
occur
AS.
The
understanding
AS
has
expanded
over
past
two
decades
greater
availability
genetic
testing
research
on
genotype-phenotype
correlation.
Patients
previously
diagnosed
with
idiopathic
steroid
resistant
nephrotic
ESKD
unknown
etiology
may
now
be
as
if
COL4A3-5
are
identified.
Some
carriers
heterozygous
classified
into
females
X-linked
autosomal
dominant
AS,
there
typical
pathologic
changes
glomerular
basement
membrane
proteinuria
progression
disease.
Lastly,
it
been
recommended
that
renin-angiotensin-aldosterone
system
inhibition
started
soon
possible
for
selected
patients
its
long-term
protective
effect
against
function
deterioration.
purpose
this
review
introduce
these
important
concepts
general
pediatricians
pediatric
nephrologists.
Abstract
Background
Chronic
inflammation
and
its
control
are
crucial
to
the
responses
of
glomerular
renal
tubular
cells.
This
contributes
pathogenic
mechanisms
advancement
disease
in
Alport
syndrome.
The
study
aimed
elucidate
role
cyclooxygenase-2,
Interleukin
4,
Plasminogen
activating
inhibitor
1,
Prostaglandin
E2
development
course
Methods
In
our
inflammatory
markers
were
evaluated
26
syndrome
patients,
15
males
11
females
24
controls.
Results
Their
age
ranged
from
4
16
years
(mean
±
SD
was
8.50
2.877)
normal
controls
matching
sex.
serum
levels
E2,
1
all
patients.
level
increased
significantly
patients
compared
(588.68
73.08,
42.57
4.18,
42.32
3.49,
846.47
45.433,
respectively
versus
(369.12
50.28,
25.52
4.98,
28.89
3.19,
312.79
40.53
respectively).
Conclusion
that
causally
connected
have
a
delineated.
may
highlight
speculate
an
innovative
strategy
for
targeting
creation
safe
efficient
anti-inflammatory
treatments
inhibit
progression
Pediatric Nephrology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 4, 2025
Abstract
Background
Chronic
kidney
disease
(CKD)
seriously
affects
the
well-being
and
shortens
life
expectancy
of
children
adolescents,
but
its
progression
is
challenging
to
predict.
Therefore,
there
an
urgent
need
for
biomarkers
that
can
identify
at
risk
faster
CKD
progression.
Alport
syndrome
(AS)
most
common
monogenetic
glomerular
disease.
Urinary
Dickkopf-related
protein
3
(
DKK3)
associated
with
a
decline
in
estimated
filtration
rate
(eGFR)
adults
advanced
CKD.
However,
potential
early
detection
prognostic
value
AS
remain
unknown.
Methods
Urine
samples
from
49
enrolled
EARLY
PRO-TECT
trial
were
analyzed
evaluate
whether
DKK3
could
be
Results
levels
patients
higher
than
those
healthy
individuals
reported
literature.
more
elevated
later
stages
AS.
Furthermore,
who
not
treated
renin
angiotensin
system
inhibitors
(RASi)
had
children.
Children
above-average
likely
have
increased
albuminuria
after
2
years
follow-up
below-average
levels.
Conclusion
significantly
There
was
association
between
levels,
worsening
albuminuria,
function.
These
findings
suggest
may
marker
predicting
damage
Graphical
Pediatric Nephrology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 5, 2025
Abstract
Background
Alport
kidney
disease
(AKD)
presents
one
of
the
most
prevalent
genetic
disorders,
characterized
by
a
complex
background
and
diverse
clinical
manifestations.
This
study
aimed
to
review
features
pediatric
patients
with
COL4A3–5
variants
identify
novel
variants.
Methods
Data
were
collected
retrospectively
at
national
level
from
up
19
years
old,
who
underwent
testing
between
2008
2023.
Patients
pathogenic
likely
included.
Their
clinical,
laboratory,
characteristics
presented.
Results
Over
15
years,
85
children
adolescents
tested
positive
for
or
Increasing
incidence
was
noted
as
became
more
prevalent.
One
patient
(1.2%)
progressed
failure
six
(7%)
had
extrarenal
involvement.
Pathogenic
in
COL4A3
,
COL4A4
COL4A5
genes
found
14
(16.4%),
34
(40.0%),
37
(43.6%)
patients,
respectively.
diagnosed
autosomal,
X-linked,
digenic
AKD
55.2%,
43.6%,
1.2%,
Eight
recorded,
their
associated
phenotype
Conclusions
expands
AKD,
presenting
on
spectrum
mild
hematuria
progressive
chronic
disease.
Genetic
confirmation
risk
stratification
population
are
critical
ensure
timely
care
potentially
slow
down
progression
Graphical
abstract
Journal of Rare Diseases,
Год журнала:
2025,
Номер
4(1)
Опубликована: Фев. 28, 2025
Abstract
Alport
syndrome
(AS)
is
a
progressive
monogenic
glomerular
kidney
disease
characterised
by
function
decline,
hearing
loss,
and
ocular
abnormalities,
often
leading
to
early-onset
failure
(KF).
While
current
therapies,
such
as
renin-angiotensin
system
inhibitors
(RASi),
offer
some
benefits,
many
patients
still
experience
KF
at
young
age,
highlighting
the
need
for
additional
treatment
options.
Glucagon-like
peptide-1
receptor
agonists
(GLP-1
RAs)
have
emerged
promising
agents
with
demonstrated
cardiovascular
nephroprotective
effects
in
type
2
diabetes
(T2D)
chronic
(CKD)
patients.
Evidence
from
several
major
clinical
trials
has
shown
that
GLP-1
RAs
can
reduce
events
slow
CKD
progression
reducing
albuminuria.
Their
potential
mechanisms
of
action
include
anti-inflammatory,
anti-fibrotic,
antioxidative
effects,
making
them
particularly
relevant
AS,
where
inflammation
fibrosis
play
crucial
roles
progression.
This
review
explores
therapeutic
summarising
pre-clinical
data
elucidating
pathways
through
which
might
renoprotective
benefits.
We
advocate
further
research
into
their
application
AS
recommend
inclusion
future
better
understand
impact
on
patient
outcomes.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Март 5, 2025
Alport
syndrome
is
a
common
monogenic
kidney
disease
resulting
from
pathogenic
variants
in
COL4A3,
COL4A4
or
COL4A5
genes.
The
estimated
global
population
prevalence
one
106
individuals
for
autosomal
dominant
(AD)
and
2,320
sex-linked
(XL)
conditions.
Here,
we
aimed
to
estimate
the
of
carrying
that
cause
Singapore,
stratify
by
ancestry.
We
used
population-scale
genomic
data
9,051
unrelated
subjects,
comprising
5,443
(60.8%)
Chinese,
1,922
(21.4%)
Indian
1,686
(17.8%)
Malay
individuals.
with
AD
XL
are
1
165
2,262
respectively.
Additionally,
0.8%
Chinese
0.3%
populations
carry
variants,
being
2.7
times
more
affected
than
Malays
(95%
CI:1.147-6.437,
P
=
0.027).
Interestingly,
each
variant
was
associated
people
single
two
most
prevalent
COL4A3:
c.3856G
>
A
(p.Gly1286Arg)
(n
8)
c.4793T
G
(p.Leu1598Arg)
4),
were
exclusively
found
population.
In
conclusion,
may
be
higher
frequencies
among
Chinese.
Furthermore,
founder
effects
exist
within
ancestries.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Март 8, 2025
Alport
syndrome
(AS)
is
the
second-most
frequent
monogenic
kidney
disease
and
85%
of
cases
are
caused
by
mutations
in
genes
α5
chains
collagen
type
IV
(COL4A5).
The
early
diagnosis
treatment
essential
for
prognosis
AS.
clinical
phenotypes
AS
very
variable,
which
challenging
to
diagnose.
Genetic
sensitive
accurate,
can
recognize
affected
individuals
with
mild
phenotype
predict
age
at
renal
failure
treatment.
In
addition,
genetic
testing
will
offer
available
reproductive
options,
including
prenatal
preimplantation
(PGT).
this
study,
three
novel
COL4A5
variants
(c.1834G
>
T,
c.865G
A
c.1032
+
5G
A)
were
found.
These
co-segregated
multiple
family
members.
vitro
splicing
assay
indicated
that
variant
resulted
aberrant
involving
exon
18
skipping.
healthy
babies
without
these
born
PGT
or
diagnosis,
respectively.
Three
gene
provide
insights
into
further
counseling
genotype–phenotype
correlations.
Orvosi Hetilap,
Год журнала:
2024,
Номер
165(28), С. 1067 - 1078
Опубликована: Июль 14, 2024
A
vérvizelés
hátterében
a
betegségek
széles
spektruma
állhat
gyermekkorban,
az
egyszerű
és
gyorsan
gyógyuló
húgyúti
fertőzésektől
progrediáló
súlyos
glomerulonephritisig,
mely
vesefunkció
gyors
romlásához
vezet.
kivizsgálása
során
ezért
elsődleges
célunk
orvosi
szempontból
jelentős
esetek
elkülönítése.
vérvizeléshez
társuló
fehérjevizelés,
magas
vérnyomás
vagy
beszűkült
progresszív
vesebetegségre
hívja
fel
figyelmet.
Amennyiben
makroszkópos,
egyéb
klinikai
tünetek
jellegzetesek,
differenciáldiagnózis
gyakran
könnyű
egyértelmű.
Komplikáltabb
esetekben
azonban
további
noninvazív
vizsgálómódszerek
lehetnek
szükségesek,
mint
ultrahangvizsgálat,
vörösvértestek
morfológiai
vizsgálata,
kalciumürítés,
vizeletkémiai
paraméterek,
illetve
fehérjevizelés
mértékének
meghatározása.
családi
anamnézis
részletes
felvétele
örökletes
okainak
elkülönítésében
segít.
Tünetmentes
esetén
központokként
változhat
vesebiopszia
elvégzésének
indikációja.
glomerularis
felismerésének
arányát
jelentősen
befolyásolja,
hogy
kritériumok
teljesülése
végzünk
vesebiopsziát.
Összefoglaló
közleményünkben
diagnosztikájának
kihívásait
mutatjuk
be.
Részletezzük
definícióját,
postglomerularis
elkülönítésének
lépéseit,
áttekintjük
hátterükben
álló
leggyakoribb
betegségeket,
melyek
gyakoriságuk,
lefolyásuk
rossz
prognózisuk
miatt
kihívást
jelentenek
mindennapi
gyermeknefrológiai
gyakorlatunk
során.
Orv
Hetil.
2024;
165(28):
1067–1078.
Molecular Syndromology,
Год журнала:
2024,
Номер
unknown, С. 1 - 6
Опубликована: Июль 24, 2024
Alport
syndrome
(AS)
is
a
rare
genetic
disorder
characterized
by
abnormalities
in
the
kidneys,
ears,
and
eyes.
Its
clinical
presentation
typically
manifests
childhood
or
adolescence
varies
widely
among
affected
individuals,
ranging
from
isolated
hematuria
to
end-stage
renal
disease.
The
causes
of
AS
primarily
involve
mutations
genes
encoding
type
IV
collagen
COL4A3,
COL4A4,
COL4A5,
which
play
essential
roles
maintaining
structural
integrity
glomerular
basement
membrane
kidney,
cochlea,
retina.
They
can
be
transmitted
autosomal
dominant,
recessive,
X-linked
recessive.
Here
we
report
Moroccan
consanguineous
family
with
an
18-year-old
girl
who
presented
advanced
failure
microscopic
hematuria.
Her
audiometry
revealed
hearing
impairment.
Urinalysis
performed
all
asymptomatic
members
showed
mother
younger
sister,
while
computed
tomography
excluded
urologic
cause.
Using
next-generation
sequencing
analysis,
identified
proband
nonsense
homozygous
variant
COL4A3
gene
(c.4114C>T,
p.Gln1372Ter)
that
was
never
reported
literature,
considered
pathogenic
according
ACMG
classification.
Segregation
analysis
parents
were
heterozygous
like
elder
brother,
whereas
sister
mutated
homozygous,
other
brother
normal.
We
novel
expends
allelic
spectrum
AS.
Clinical
exploration
testing
intrafamilial
variability,
suggesting
pseudo-dominant
inheritance
reduced
penetrance.